Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 437, 25 (1 September 2005) | doi:10.1038/437025a; Published online 31 August 2005
In brief
The US Food and Drug Administration last week approved a genetic test that identifies patients who are at increased risk of suffering side effects from a drug commonly used to treat colon cancer. The test, known as the Invader UGT1A1 Molecular Assay, is made by Third Wave Technologies in Madison, Wisconsin.
To read this story in full you will need to login or make a payment (see right).
HTTP Status 500 -
type Exception report
message
description The server encountered an internal error () that prevented it from fulfilling this request.
exception
javax.servlet.ServletException: Servlet execution threw an exception
root cause
java.lang.OutOfMemoryError
note The full stack trace of the root cause is available in the Tomcat logs.